Streptococcal infections can be caused by a variety of Streptococcus bacteria. Streptococci are classified based on their hemolytic properties and Lancefield antigens. Identification requires examining gram stain morphology, hemolytic patterns, biochemical reactions, and genetic analysis. Pathogenic species like S. pyogenes and S. agalactiae can cause diseases ranging from pharyngitis to necrotizing fasciitis through direct invasion and toxin production. Diagnosis involves culture and identification of the isolated strain. Treatment focuses on appropriate antibiotic therapy.

1. STREPTOCOCCAL
INFECTIONS
1

2. 2
INTRODUCTION:
•STREPTOCOCCI are widely distributed in nature and
some are members of the normal flora while others are
pathogenic
•Pathogenicity can be attributed in part to
• Infection by the organism, and
• Sensitization to them
•They elaborate a variety of extracellular substances and
enzymes
•They are a large and heterogeneous group of bacteria
impossible to classify into one system
•Classification by various properties is key to understanding
their medical importance.

3. 3
IDENTIFICATION:
•Gram positive spheres (cocci) like staphylococci
•But unlike staphylococci that appear in clusters, streptococci
appear in strips (chains) on gram stain – determined by their
planes of division
•1µm in diameter and usually capsulated
•Facultative anaerobes (some species – microaerophilic)
• Some – Capnophilic
•For most – growth and hemolysis are aided by incubation in 10% CO2
•They are catalase negative
•Non-sporing bacteria and non-motile.
•Growth requires enriched media containing blood or serum.

4. IDENTIFICATION:
• Catalase test:
•Catalase converts H2O2(which is used by macrophages and neutrophils) to
Water and O2
4
Catalase +ve
Staphylococci
Catalase –ve
Streptococci

5. 5
CLASSIFICATION:
• Based on the hemolytic properties:
▪ Beta-hemolytic: - clear zone of hemolysis around the colony
▪ Alpha-hemolytic: - greenish discolouration of the culture medium around the
colony (partial hemolysis)
▪ Gamma-hemolytic: - no hemolysis of RBCs (Non-hemolytic streptococci)
• Based on antigenic characteristics of cell wall CHO (C – carbohydrate)
–Lancefield Antigens (Serologic Classification from A to V):
▪ Out of over 30 species of streptococci, only 5 are significant human
pathogens
▪ 3 have Lancefield Antigens:
▪ Group A – (S. pyogenes),
▪ Group B – (S. agalactiae), and
▪ Group D – (Enteroccoci + Non-enterococci)
▪ 2 have no Lancefield antigens – Lancefield Non-groupable:
▪ S. pnuemoiae, and
▪ Viridans group Streptoccoci

6. CLASSIFICATION:
• Hemolysis on Blood agar:
6

7. 7
CLASSIFICATION:
•Historically, Lancefield antigens have been used as a major
way of differentiating the many streptococci though not
applicable to a number of organisms including some
pathogenic species
•Identification of Streptococcal organisms require a
combination of several characteristics including:
• Antigenic composition including Lancefield antigens,
• Patterns of hemolysis,
• Biochemical reactions,
• Growth characteristics, and
• Genetic studies

8. CLASSIFICATION:
8

9. CLASSIFICATION:
9

10. 10
BIOCHEMICAL REACTIONS:
Differentiation between beta-hemolytic
streptococci:
•Bacitracin susceptibility test
•CAMP test
•Bile Esculin Test

11. 11
BIOCHEMICAL REACTIONS:
Bacitracin Test -
• Bacitracin susceptibility Test:
• Specific for S. pyogenes (Group A) – for its presumptive identification
• Principle:
• To distinguish between S. pyogenes (susceptible to B) & non group A such
as S. agalactiae (resistant to B)
• Bacitracin will inhibit the growth of Group A – S. pyogenes giving zone of
inhibition around the disk
• Procedure:
• Inoculate BAP with heavy suspension of tested organism
• Bacitracin disk (0.04 U) is applied to inoculated BAP
• After incubation, any zone of inhibition around the disk is considered as
susceptible

12. BIOCHEMICAL REACTIONS:
Bacitracin Test:
12

13. 13
BIOCHEMICAL REACTIONS:
CAMP test – (Christie Atkins Munch-Petersen)
•Principle:
• Group B streptococci produce extracellular protein (CAMP factor)
• CAMP act synergistically with staph. beta-lysin to cause lysis of RBCs
•Procedure:
• Single streak of streptococci to be tested and staph. aureus are
made perpendicular to each other
• 3 – 5mm distance was left between two streaks
• After incubation, a positive result appear as an arrowhead shaped
zone of complete hemolysis
•S. agalactiae is CAMP test positive while non-group B
streptococci are negative

14. BIOCHEMICAL REACTIONS:
CAMP test -
14

15. 15
BIOCHEMICAL REACTIONS:
Bile Esculin Test -
• Differential agar (BEA) used to isolate and identify Enterococcus
(group D streptococci) and differentiate it from other streptococci
• Bile salts are the selective component, while Esculin is the
differential component
• Must be interpreted in conjunction with gram stain morphology
• Principle:
• Enterococcus hydrolyze Esculin liberating glucose (which is used up) and
Esculetin.
• Esculetin react with ferric citrate in the medium to produce insoluble iron
salts, resulting in the blackening of the medium
• Many bacteria can hydrolyze Esculin, but only few can do so in the presence

16. BIOCHEMICAL REACTIONS:
Bile Esculin Test:
•After a maximum of
48hrs incubation,
•Less than half
darkened agar slant –
Negative result.
•Greater than half
darkened agar slant –
Positive result.
16

17. 17
BIOCHEMICAL REACTIONS:
Differentiation between alpha-hemolytic
Streptococci
•Optochin test
•Bile solubility test
•Inulin fermentation

18. 18
BIOCHEMICAL REACTIONS:
Optochin test -
•Principle:
• S. pneumonia is inhibited by Optochin reagent (<5 μg/mL) giving
an inhibition zone of ≥14mm in diameter.
•Procedure:
• BAP is inoculated with the organism to be tested and an Optochin
disc placed in the center of the plate
• After incubation at 37oC for 18hrs, carefully measure the
diameter of the inhibition zone with a ruler
• ≥14mm is positive; ≤ 13mm is negative
•S. pneumonia is positive (S); S. viridans is negative (R)

19. BIOCHEMICAL REACTIONS:
Optochin test -
19

20. 20
BIOCHEMICAL REACTIONS:
Bile solubility test -
•Principle:
• S. pneumonia produce a self-lysing enzyme capable of inhibiting its
growth and this is accelerated in the presence of bile.
•Procedure:
• Add 10 parts of the broth culture of the organism to be tested to
one part of 2% Na-deoxycholate (bile) in a test-tube
• Negative control is made by adding saline instead of bile to the
culture
• Incubate at 37oC for 15mins
• Observe and record your findings.

21. BIOCHEMICAL REACTIONS:
Bile solubility test -
• Clearing in the presence
of bile – positive;
turbidity – negative.
• S. pneumonia is soluble
in bile – positivity,
whereas
• S. viridans are insoluble
in bile – negativity.
21

22. BIOCHEMICAL REACTIONS:
Insulin fermentation -
• Useful to differentiate
Pneumococci from
other Streptcocci:
• Pneumococci ferments
inulin
22

23. IDENTIFICATION OF beta- and alpha-
HEMOLYTIC STREOTOCOCCI:
ferment
23
Not ferment

24. STREPTOCOCCAL VIRULENCE
FACTORS
24

25. STREPTOCOCCI – DISEASES:
25

26. 26
GROUP A: Streptococcus pyogenes
METABOLISM:
•Catalase – negative
•Microaerophilic
•Beta-hemolytic – due to enzymes that destroy blood cells
• Streptolysin-O:
• Oxygen labile
• Antigenic
• Streptolysin-S:
• Oxygen stable
• Non-antigenic

27. 27
VIRULENCE:
• M-protein (70 types) – major virulence factor
• Adherence factor
• Antiphagocytic
• Antigenic: induces antibodies which can lead to phagocytosis
• Lipoteichoic acid:
• Adherence factor
• Streptokinase - FIBRINOLYSIN
• Hyaluronidase – destroys CT and aids spread of the organism
• DNAase (Streptodornase)
• Anti-C5a peptidase – prevents C5a mediated phagocytic activity
• Protein F -
• Streptolysin O – also antigenic; (but Streptolysin S – not antigenic)
• Hence Anti-Streptolysin O (ASO) antibody titer rises in recent infections
• Skin infection does not induce ASO

28. 28
TOXINS:
•Erythrogenic or pyrogenic toxin (produced only by
lysogenized Group A Streptococci): responsible for
scarlet fever
•More than 4 serologically distinct toxins (Spe - A, B, C and F).
•Dick Test: once commonly used to confirm Scarlet Fever
diagnosis.
•Some strains produce pyrogenic exotoxins which act as
superantigens that superstimulate T cell leading to release
of cytokine which cause the Toxic shock syndrome.
•Toxic shock syndrome toxin (similar to, but different
from the staph exotoxin TSST-1)

29. 29
PATHOLOGY:
DIRECT INVASION/TOXIN:
•Pharyngitis:
• Red, Swollen tonsils and pharynx
• Purulent exudate on tonsils
• Fever
• Swollen lymph nodes
•Skin infections:
• Folliculitis, Erysipelas, pyoderma
• Cellulitis
• Impetigo
• Necrotizing fasciitis
•Scarlet fever: - fever and scarlet red rash on body
•Toxic shock syndrome

30. 30

31. Necrotizing fascitis
31

32. 32
PATHOLOGY:
ANTIBODY MEDIATED (Delayed):
•Rheumatic fever (may follow streptococcal pharyngitis):
• Fever
• Myocarditis: heart inflammation >> Rhuematic valvular heart disease many
years later.
• Arthritis: migratory polyarthritis
• Chorea (Sydenham’s chorea or St. Vitus dance)
• Rash: Erythema marginatum
• Subcutaneous nodules: 10 – 20 yrs after infection, may develop permanent
heart valve damage
•Acute post-streptococcal Glomerulonephritits:
• Tea or coca cola coloured urine, following streptococcal skin or pharynx
infection
• Follows skin or throat infection by Nephritogenic strains

33. 33
DIAGNOSIS:
•Gram stain: - gram positive cocci in chains
•Culture on standard laboratory media: - Growth is inhibited
by bacitracin
• S. pyogenes is the only beta-hemolytic strep which is sensitive to
bacitracin
•Pharyngitis: - Throat swab rapid antigen detection test
(RADT) is specific for S. pyogenes and immunologically
detects group A carbohydrate antigen.
• In children, RADT should be backed up by a throat culture due to
the high incidence of “strep throat” and moderate sensitivity to
RADT.

34. 34
TREATMENT:
• Penicillin G
• Penicillin V
• Penicillinase-resistant penicillin e.g Dicloxacillin: in skin infections,
where staphylococci could be the responsible organism
▪ Following rheumatic fever:
▪ Patients are placed on continuous prophylactic antibiotics to prevent repeat
strep throat infection that could potentially lead to repeat case of rheumatic
fever
▪ For invasive S. pyogenes infections, such as necrotizing fasciitis or
streptococcal toxic shock syndrome, consider adding Clindamycin.

35. 35
GROUP B: Streptococcus agalactiae
METABOLISM:
•Catalase – negative
•Facultative anaerobe
•Beta-hemolytic
•Part of normal flora:
• 25% of pregnant women carry Group B streptococci in their vagina.
• Can be transmitted to neonates during birth

36. 36
PATHOLOGY:
• Neonatal meningitis
• Neonatal pneumonia
• Neonatal sepsis
• Sepsis in pregnant women (with secondary infection of fetus)
• Increasing incidence of infections in elderly >65yrs of age and
patients with diabetes or neurological disease: causes sepsis and
pneumonia

37. 37
DIAGNOSIS:
• Gram stain of CSF or Urine: - positive cocci in chains
• Culture of CSF, Urine or Blood

38. 38
TREATMENT:
• Penicillin G

39. 39
GROUP C and G Streptococcus:
• Beta-hemolytic
• S. equi, S. canis
• Associated diseases:
• Pharyngitis, pneumonia, cellulitis, pyoderma, erysipelas, impetigo, wound
infections, puerperal sepsis, neonatal sepsis, endocarditis, septic arthritis
• Treatment:
• Penicillin, vancomycin, cephalosporins, macrolides (variable susceptibility)

40. GROUP D Streptococcus:
• 2 SUB-TYPES:
• Enterococci: (recently given their own genus
because they sufficiently differ from the
streptococci)
• S. faecalis
• S. faecium
• Non-enterococci:
• S. bovis
• S.equinus
• Enterococcus:
• Gram +ve cocci
• Singly/in pairs/short chains Enterococci
40

41. 41
METABOLISM:
• Catalase – Negative
• Facultative anaerobes
• Usually Gamma-hemolytic, but maybe alpha-hemolytic
• Positive bile esculin test

42. 42
VIRULENCE:
• Extracellular dextran helps them bind to heart valves

43. 43
PATHOLOGY:
•Sub-acute bacterial endocarditis
•Biliary tract infections
•Urinary tract infections (especially the Enterococci)
•S. bovis is associated with colonic malignancies

44. 44
DIAGNOSIS:
•Gram stain – positive cocci in chains
•Culture:
• Enterococci can be cultured in:
• 40% bile
• 6.5% Sodium chloride
• Non-enterococci can only grow in bile

45. 45
TREATMENT:
•Ampicillin, sometimes combined with an aminoglycoside
•Resistant to Penicillin G
•Emerging resistance to vancomycin
•For vancomycin resistant organisms (VRE), consider Linezolid,
Daptomycin and Nitrofurantoin.

46. 46
VIRIDANS GROUP Streptococci:
• Part of normal oral flora,
• Found in the nasopharynx and gingivial crevices
• GI tract
• Members:
• Mitis group: S. mitis, S. sanguis, S. parasanguis, S. gordonii, S. crista, S.
infantis, S. oralis, S. peroris
• Salavarius group: S. salavarius, S. vestibularis, S. thermophiles
• Mutans group: S. mutans, S. sobrinus, S. criceti, S. rattus, S. downeii, S.
macacae
• Angionosus group: S. angionosus, S. constellatus, S. intermedius

47. 47
METABOLISM:
• Catalase – negative
• Facultative anaerobes
• Mostly alpha-hemolytic; some beta- and gamma
• Resistant to Optochin
• Bile solubility - Negative

48. 48
VIRULENCE:
• Extracellular dextran – helps them bind to heart valves

49. 49
PATHOLOGY:
• Sub-acute bacterial endocarditis: caused by S. mitis group
• Dental caries (cavities): caused by S. mutans group
• Brain or Liver abscesses: caused by S. angionosus group
• Microaerophilic
• Found alone in pure cultures or in mixed cultures with anaerobes

50. DIAGNOSIS:
• Gram stain
• Culture – antibiotics may be added to inhibit growth
of contaminating bacteria
• Resistant to optochin
• Detection of group A streptococci by molecular
methods: PCR assay for pharyngeal specimens
• Antibody detection
• ASO titration for respiratory infections.
• Anti-DNAase B and Antihyaluronidase titration for
skin infections.
• Anti-streptokinase; Anti-M type-specific antibodies
50

51. 51
TREATMENT:
• Penicillin G
• Effective doses of penicillin or erythromycin for 10 days can prevent
post-streptococcal diseases.
• Drainage and aggressive surgical debridement must be promptly
initiated in patients with serious soft tissue infections.
• Antibiotic sensitivity test is helpful for treatment of bacterial
endocarditis.

52. 52
Streptococci Pneumoniae
(Pnuemococcus):
METABOLISM:
•Gram-positive lancet-shaped diplococci.
•Alpha-hemolytic (Pneumolysin is similar to streptolysin O).
•Form small round colonies on the plate, at first dome-shaped
and later developing a central plateau with an elevated rim.
•Facultative anaerobe
•Autolysis is enhanced in bile salt.
•Growth is enhanced by 5-10% CO2 – capnophilic.

53. 53
VIRULENCE:
• Polysaccharide Capsule (90 serotypes):
• Protects the organism from phagocytosis
• Highly antigenic – opsonized by antibodies specific to it
• Due to the variable serotypes, surviving an infection from one serotype does
not confer immunity over the others
• Cell wall polysaccharide
• Phosphocholine
• Pneumolysin
• IgA protease, etc.

54. 54
TOXINS:
•Pneumolysin: binds to cholesterol in host-cell membranes
(but its actual effect is unknown)
•MAJOR HOST DEFENCE MECHANISM: - Ciliated Cells of the
Resp tract and Spleen
•Loss of natural resistance may be due to:
• Abnormalities of the respiratory tract (e.g. viral RT infections).
• Alcohol or drug intoxication; abnormal circulatory dynamics.
• Patients undergone renal transplant; chronic renal diseases.
• Malnutrition, general debility, sickle cell anemia,
hyposplenism or splenectomy, nephrosis or complement
deficiency
• Young children and the elderly

55. 55
PATHOLOGY:
• Pnuemonia – pneumococcus is the most common cause of
pneumonia in adults
• Meningitis – most common cause of bacterial meningitis in adults
• Sepsis
• Otitis media (most common cause in children)

56. DIAGNOSIS:
• Gram stain: - reveals gram-positive
diplococcic
• Culture: does not grow in presence of:
• Optochin
• Bile
• Capsular polysaccharide antigen
detection
• DNA probe specific to S. pneumonia
• Virulence to mice
Pneumococcus Specific DNA probe
56

57. DIAGNOSIS:
• Positive Quellung test:
swelling when tested
against antiserum
containing anti-capsular
antibodies
• Quellung reaction:
technique used to
detect encapsulated
bacteria (such as S.
pneumonia and H.
influenza)
Quellung Antibody reaction
57

58. 58
TREATMENT:
• Penicillin G (IM)
• Erythromycin
• Ceftriaxone
• Vaccine: made against 23 most common capsular antigens.
• Vaccinate individuals who are susceptible such as elderly or asplenic
individuals (including being functionally asplenic due to sickle cell anaemia)
• Pnuemococcal conjugate vaccine - Capsular polysaccharide + Protein Carrier
• Below 2yrs
• Heptavalent and the newer 13 valent conjugated vaccines are
effective at preventing otitis media and pneumonia.

59. 59
CONCLUSION:
• STREPTOCOCCI are widely distributed in nature and some are
members of the normal flora while others are pathogenic
• Pathogenicity can be attributed in part to
• Infection by the organism, and
• Sensitization to them
• They elaborate a variety of extracellular substances and enzymes
• They are a large and heterogeneous group of bacteria impossible to
classify into one system
• Classification by various properties is key to understanding their
medical importance.